10-K - Silo Pharma, Inc. (0001514183) (Filer) March 27, 2026 4:40 pm | NASD Silo Pharma Inc. Annual Report - Key Insights for Investors ...
8-K - Silo Pharma, Inc. (0001514183) (Filer) February 23, 2026 5:00 pm | NASD Silo Pharma Announces Share Buyback Program - Investor Summa...
Silo Pharma, Inc. 2025 Annual Report: Product Development, Intellectual Property, and Regulatory Risk Factors March 28, 2026 Silo Pharma Inc. Annual Report - Key Insights for Investors ...
COMPASS Pathways: COMP360 Psilocybin Treatment for Mental Health – Clinical Trials, Strategy, Risks, Patents, and Commercialization 3144535455 March 24, 2026 Compass Pathways 2025 Annual Report: Key Highlights and Inve...
Beng Kuang Marine and Epsilon Navigation Form Joint Venture for Offshore Marine Asset Monetisation Platform March 6, 2026 Beng Kuang Marine Announces Joint Venture with Epsilon Navig...
Silo Pharma Announces $1 Million Share Buyback Program to Enhance Shareholder Value February 24, 2026 Silo Pharma Announces Share Buyback Program - Investor Summa...
